文献速递心血管外周血管DSA

低内皮剪切应力与斑块特征在预测非罪犯主要不良心脏事件中的作用:PROSPECT研究

Role of Low Endothelial Shear Stress and Plaque Characteristics in the Prediction of Nonculprit Major Adverse Cardiac Events: The PROSPECT Study.
PubMed 文献 · JACC Cardiovasc Imaging · 2017-09-18

基于PROSPECT研究中697例ACS患者的三支血管内成像,分析97例患者145个非罪犯病变的基线内皮剪切应力(ESS)与后续非罪犯主要不良心脏事件(nc-MACE)的关系。低局部ESS(<1.3 Pa)与nc-MACE强相关(HR 4.34,95%CI 1.89–10.00,P<0.001),且与高解剖风险特征协同:高解剖风险/低ESS组3年nc-MACE率52.1%,低解剖风险/低ESS组14.4%,生理/高ESS组0.0%(P<0.0001)。

要点

  • 低局部ESS(<1.3 Pa)是未来nc-MACE的独立预测因子(HR 4.34,95%CI 1.89–10.00,P<0.001)。
  • 高解剖风险(PB≥70%、MLA≤4 mm²或TCFA中≥2项)合并低ESS时3年nc-MACE率达52.1%。
  • 随访期间无低ESS的病变均未导致nc-MACE,无论基线PB、MLA或斑块形态如何。

核心结论

  • 局部低ESS可在斑块负荷、最小管腔面积和形态学指标之外,为高危患者未治疗冠状动脉病变提供增量风险分层。

研究设计与样本

  • PROSPECT研究事后分析,97例ACS患者共145个非罪犯病变(23个nc-MACE病变,122个nc-non-MACE病变),行三支血管冠状动脉内成像并计算基线ESS,随访3.4年,采用倾向评分校正的Cox回归分析。

关键影像表现/征象

  • 23个nc-MACE病变中13个为薄纤维帽粥样斑块(TCFA)、10个为厚纤维帽粥样斑块(ThCFA);122个nc-non-MACE病变中63个为TCFA、59个为ThCFA。

诊断标准与关键数值

  • 低局部ESS定义为<1.3 Pa,生理/高ESS定义为≥1.3 Pa。
  • 低ESS组nc-MACE发生率为22.8%(23/101),生理/高ESS组为0%(0/44)。
  • 倾向校正Cox回归中低ESS与MACE的HR为4.34(95%CI 1.89–10.00,P<0.001)。
  • 高解剖风险定义为PB≥70%、MLA≤4 mm²或TCFA中至少2项高危特征。
  • 3年nc-MACE率:高解剖风险/低ESS组52.1%,低解剖风险/低ESS组14.4%,生理/高ESS组0.0%(P<0.0001)。

临床应用与阅片要点

  • 原文结论指出,局部低ESS可在斑块负荷、最小管腔面积和形态学指标之外,为高危患者未治疗冠状动脉病变提供增量风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study sought to determine whether low endothelial shear stress (ESS) adds independent prognostication for future major adverse cardiac events (MACE) in coronary lesions in patients with high-risk acute coronary syndrome (ACS) from the United States and Europe.

BACKGROUND: Low ESS is a proinflammatory, proatherogenic stimulus associated with coronary plaque development, progression, and destabilization in human-like animal models and in humans. Previous natural history studies including baseline ESS characterization investigated low-risk patients.

METHODS: In the PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) study, 697 patients with ACS underwent 3-vessel intracoronary imaging. Independent predictors of MACE attributable to untreated nonculprit (nc) coronary lesions during 3.4-year follow-up were large plaque burden (PB), small minimum lumen area (MLA), and thin-cap fibroatheroma (TCFA) morphology. In this analysis, baseline ESS of nc lesions leading to new MACE (nc-MACE lesions) and randomly selected control nc lesions without MACE (nc-non-MACE lesions) were calculated. A propensity score for ESS was constructed for each lesion, and the relationship between ESS and subsequent nc-MACE was examined.

RESULTS: A total of 145 lesions were analyzed in 97 patients: 23 nc-MACE lesions (13 TCFAs, 10 thick-cap fibroatheromas [ThCFAs]), and 122 nc-non-MACE lesions (63 TCFAs, 59 ThCFAs). Low local ESS (<1.3 Pa) was strongly associated with subsequent nc-MACE compared with physiological/high ESS (≥1.3 Pa) (23 of 101 [22.8%]) versus (0 of 44 [0%]). In propensity-adjusted Cox regression, low ESS was strongly associated with MACE (hazard ratio: 4.34; 95% confidence interval: 1.89 to 10.00; p < 0.001). Categorizing plaques by anatomic risk (high risk: ≥2 high-risk characteristics PB ≥70%, MLA ≤4 mm2, or TCFA), high anatomic risk, and low ESS were prognostically synergistic: 3-year nc-MACE rates were 52.1% versus 14.4% versus 0.0% in high-anatomic risk/low-ESS, low-anatomic risk/low-ESS, and physiological/high-ESS lesions, respectively (p < 0.0001). No lesion without low ESS led to nc-MACE during follow-up, regardless of PB, MLA, or lesion phenotype at baseline.

CONCLUSIONS: Local low ESS provides incremental risk stratification of untreated coronary lesions in high-risk patients, beyond measures of PB, MLA, and morphology.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Stone PH, Maehara A, Coskun AU, et al. Role of Low Endothelial Shear Stress and Plaque Characteristics in the Prediction of Nonculprit Major Adverse Cardiac Events: The PROSPECT Study. JACC Cardiovasc Imaging. 2017. PMID: 28917684. doi:10.1016/j.jcmg.2017.01.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。